Complete a quick online intake form on our website
In its fourth-quarter 2022 financial results, Lilly said the growth was driven by increased demand, partially offset by lower realized prices. Outside the US, revenue was $409.8 million, a decrease of six percent, which the company said was driven by the unfavorable impact of foreign exchange rates and to a lesser extent, lower realized prices, partially offset by increased demand. But on a constant currency basis, non-US revenue increased eight percent
Next year, Hims & Hers will move into Canada with its digital weight loss program as the market for generic GLP-1 weight loss drugs is set to open up
FDA-Approved Peptide Medications We Prescribe At Klinic in Reston, Virginia, we provide only branded, FDA-approved peptide medications
4.3 Ethnicity differences In general, Indians had the highest GLP-1 responses, followed by Chinese and Malays
90-100% concordance of Type 2 diabetes in MZ twins